炎症比率作为切除胃腺癌的生存预后因素

Vlad-Ionuţ Nechita1,2, Nadim Al-Hajjar2,3, Daniel-Corneliu Leucuța1

  • 1Department of Medical Informatics and Biostatistics, "Iuliu Hațieganu" University of Medicine and Pharmacy, Louis Pasteur Street, No. 6, 400349 Cluj-Napoca, Romania.

概括

手术前中性粒细胞与淋巴细胞比率 (NLR) 的升高与胃癌患者的整体存活率较差有关. 其他炎症标志物,如血小板与淋巴细胞比率 (PLR),淋巴细胞与单细胞比率 (LMR) 和全身免疫炎症指数 (SII) 没有显示预后值.